Stock screener

VCEL

Conviction 100HealthcareScan · Mon, Aug 10, 2026
VCEL$43.93-2.57%
ResistanceSupportVol 14Insider sell
63 bars
5
2
2
Vol MA14 538.03K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Vericel CorpBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.vcel.com ↗
Price43.93
Change-2.57%
Gap-2.72%
Rel volume2.04×
Avg volume525.21K
Avg $ vol24.09M
SMA 2045.88
SMA 5042.88
SMA 20037.69
Price vs 50+2.45%
Price vs 200+16.55%
MA stackbullish
50/200 cross—
Supertrendup · 42.59
RSI (14)45
MACD hist-0.49
MACD cross—
Stoch %K / %D3 / 13
ADX (14)27
+DI / −DI21 / 19
RSI divergence—
MACD divergence—
ATR %+3.72%
ADR %3.47%
52w high48.31
52w low29.34
From 52w high-9.07%
Above 52w low+49.73%
New 52w highNo
SqueezeOn · 4d
Bollinger width8.50%
%B-0.00
Donchian pos3.06%
Donchian high49.32
Donchian low43.76
AVWAP (52w high)45.81
vs AVWAP high-4.11%
AVWAP (52w low)38.70
vs AVWAP low+13.52%
OBV trendFlat
Chaikin MF (20)-0.13
Today vs 20d2.04×
Avg vol (14d)538.03K
Avg vol (20d)525.21K
Avg $ vol (20d)24.09M
Market cap2.25B
RS 3m (vs SPY)+22.65%
RS 6m (vs SPY)+13.33%
RS line new highNo
Trend template8/8
Technical rank62.6
1 week-4.60%
1 month-6.53%
3 months+31.29%
6 months+21.39%
1 year+21.52%
YTD+23.36%
P/E136.19
P/B6.08
P/S8.14
P/FCF90.90
EPS0.3200
Div yield—
ROE4.46%
ROA3.28%
Debt/Eq0.04
Current5.04
EV/EBITDA94.62
Gross margin74.42%
Net margin5.98%
Rev growth16.45%
EPS growth59.41%
Price target61.50
Target upside40.00%
Analyst ratingBuy
Institutional117.24%
Ent. value2.14B
Revenue77.46M
Net income2.21M
Gross profit56.4M
Free cash flow24.75M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out51.07M
Employees398
ListedTue, Feb 4, 1997
Free float47.06M
Float %92.4%
Short interest4.6M
Days to cover9.1d
Short volume62.5%
Squeeze score75 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.04 vs −$0.04
Last surprise+200.0% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank62.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance49.04
Support44.26
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VCEL

All disclosures →
No recent disclosed trades by Congress in VCEL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VCEL · 6 buys · 4 sells

InsiderSideShares
Halpin Michael
Chief Operating Officer · Common Stock · 2026-08-03
Exercise10K
Halpin Michael
Chief Operating Officer · Common Stock · 2026-08-03
Sell10K
Halpin Michael
Chief Operating Officer · Stock Option (Right to Buy) · 2026-08-03
Exercise10K
Flynn Sean C.
Chief Legal Officer · Common Stock · 2026-06-26
Exercise15K
Flynn Sean C.
Chief Legal Officer · Common Stock · 2026-06-26
Sell15K
Flynn Sean C.
Chief Legal Officer · Stock Option (Right to Buy) · 2026-06-26
Exercise15K
Hopper Jonathan Mark
Chief Medical Officer · Common Stock · 2026-06-26
Exercise5K
Hopper Jonathan Mark
Chief Medical Officer · Common Stock · 2026-06-26
Sell5K
Hopper Jonathan Mark
Chief Medical Officer · Stock Option (Right to Buy) · 2026-06-26
Exercise5K
Mara Joseph Anthony Jr
Chief Financial Officer · Common Stock · 2026-06-26
Sell5K

SEC filings

EDGAR filings in VCEL · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.